Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:04 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Single-center Pilot Study Evaluating the Immediate Effects of Low-dose Acetazolamide on Respiratory Control in Subjects With Treatment Emergent Sleep Disordered Breathing
NCT02670096 · NYU Langone Health · NA · withdrawn · last registry update 2017-01-24 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, NYU Langone Health |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CA1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2018-01-18Results posted on the registry: Stanford University, Budesonide + Acetazolamide (NCT02604173)
- 2017-04-14Results posted on the registry: Katrin Lorenz, Trabeculectomy with preoperative Diamox/DexaEDO treatment + Trabeculectomy with preoperative Cosopt S treatment (NCT01228149)
- 2017-04-13Also stopped (terminated): Rabin Medical Center, Acetazolamide + sugar pill (NCT02163330)
- 2017-02-10Also stopped (withdrawn): Georgetown University, acetazolamide + Quinine (NCT02276989)
- 2016-10-26Phase 3 first posted: Universidad Peruana Cayetano Heredia, Acetazolamide + Dexamethasone (NCT02945527)
- 2016-09-16Phase 3 first posted: Mayo Clinic, Diazepam + Acetazolamide (NCT02904265)
- 2016-07-13Phase 3 first posted: Boehringer Ingelheim, Loxoprofen sodium + Methocarbamol (NCT02831569)
- 2016-04-28Phase 3 first posted: University of Zurich, Acetazolamide + Placebo (NCT02755298)
- 2016-04-28Phase 3 first posted: University of Zurich, Acetazolamide + Placebo (NCT02755259)
- 2016-03-14Results posted on the registry: VA Office of Research and Development, Acetazolamide + Buspirone (NCT00746954)
- 2016-03-14Also stopped (terminated): VA Office of Research and Development, Acetazolamide + Buspirone (NCT00746954)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision